Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
13.82
+1.23 (9.77%)
At close: Jun 18, 2026, 4:00 PM EDT
14.14
+0.32 (2.33%)
After-hours: Jun 18, 2026, 7:57 PM EDT
Nuvectis Pharma Employees
Nuvectis Pharma had 12 employees as of March 31, 2026. The number of employees decreased by 1 or -7.69% compared to the same quarter last year.
Employees
12
Change
-1
Growth
-7.69%
Revenue / Employee
n/a
Profits / Employee
-$2,465,750
Market Cap
366.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 12 | -1 | -7.69% |
| Dec 31, 2025 | 13 | 0 | - |
| Sep 30, 2025 | 13 | 0 | - |
| Jun 30, 2025 | 13 | 0 | - |
| Mar 31, 2025 | 13 | 0 | - |
| Dec 31, 2024 | 13 | 0 | - |
| Sep 30, 2024 | 13 | 0 | - |
| Jun 30, 2024 | 13 | - | - |
| Dec 31, 2023 | 13 | 2 | 18.18% |
| Dec 31, 2022 | 11 | 3 | 37.50% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| Verastem | 102 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
| Atea Pharmaceuticals | 55 |
NVCT News
- 8 days ago - Nuvectis Pharma price target raised to $13 from $10 at H.C. Wainwright - TheFly
- 9 days ago - Nuvectis Pharma Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Nuvectis Pharma Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 5 weeks ago - Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 5 weeks ago - Nuvectis Pharma Slides: Corporate presentation - Filings
- 6 weeks ago - Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 6 weeks ago - Nuvectis Pharma Earnings release: Q1 2026 - Filings
- 6 weeks ago - Nuvectis Pharma Quarterly report: Q1 2026 - Filings